Treatment of Patients With RAD001 With Progressive Sarcoma
NCT00767819
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class
Conditions
Progressive Sarcoma
Interventions
DRUG:
Everolimus
Sponsor
Novartis Pharmaceuticals